Urine Culture Report: Colony Count, S/I/R and Which Antibiotic

01

Does 'no growth' mean there is no infection?

Usually it means no bacteria grew in the number and under the conditions the laboratory tested for, which is genuinely reassuring when you had no symptoms. But a sterile report does not always close the case. The commonest reason for a falsely negative culture is that an antibiotic had already been started, even one dose or a leftover strip from home, which suppresses growth without necessarily clearing the infection.

Other reasons are technical. Very dilute urine after drinking a lot of water, a sample that sat too long or was collected soon after you last passed urine, and organisms that need special media can all give no growth. If your symptoms are convincing and persistent, tell your doctor about any antibiotic you took, and expect them to treat the person rather than the paper. A report of mixed growth of two or more organisms usually points to contamination and is best repeated with a proper midstream technique.

02

10⁴ versus 10⁵ CFU/mL — which colony count is significant?

CFU stands for colony-forming units, an estimate of how many live bacteria were in each millilitre of your urine. The historic and still widely used cut-off for calling a culture positive is 100,000 (10⁵) CFU per millilitre of a single organism. That threshold was designed to separate true bladder infection from skin bacteria picked up on the way out, and it works well for screening.

It is also known to be too high for some real infections. Reference summaries note that laboratories commonly set the bar at 100,000 or more, while acknowledging that this can miss relevant infections, and that in a person with typical symptoms a count above 1,000 CFU per millilitre can already be meaningful. For catheter-associated infection the accepted threshold is around 1,000 CFU per millilitre with no more than two organisms and compatible symptoms. So a report of 10,000 CFU per millilitre in someone with clear burning and urgency is not automatically negative — it is a number your doctor reads alongside your symptoms and the pus-cell count.

03

How to read the S, I and R columns

The sensitivity panel is not a ranking of drug strength. S means susceptible at a standard dosing regimen — a high likelihood that a normal course reaches concentrations that work. R means resistant — a high likelihood of failure even with increased exposure. The letter to understand is I. Since 2019 the European breakpoint committee redefined I as 'susceptible, increased exposure': the drug can still work, but only if the dose, the dosing frequency or the site concentration is higher than standard.

That redefinition matters for urine specifically, because some antibiotics are concentrated many times over in urine compared with blood. A drug that looks marginal on the panel may be perfectly effective in the bladder, and a drug that looks excellent may not reach infected kidney tissue well. Read the report as a map of options for your organism, not as a scoreboard, and let the person prescribing match it to where the infection actually is.

04

Why E. coli is the usual finding

Escherichia coli is the most common cause of urinary tract infection in both outpatient and hospital settings, followed at some distance by coagulase-negative staphylococci, Klebsiella, Proteus and Enterobacter. The reason is anatomical rather than mysterious. E. coli lives normally in the bowel, and the short distance between the anus, the urethral opening and the bladder — shorter in women — gives it an easy route upward.

Because the same few organisms turn up again and again, laboratories and prescribers know roughly what to expect before the culture returns, which is why a first uncomplicated bladder infection is often treated empirically while the culture is still incubating. Finding E. coli on your report is therefore ordinary news, not a sign that something unusual is wrong. Less common organisms such as Proteus are more interesting, because they raise urine alkalinity and are associated with a particular kind of stone.

05

Why your doctor may not pick the newest 'sensitive' drug

Everything marked S will probably work, so the choice among them is made on other grounds: which drug concentrates in urine, which one spares the bowel flora, which has the fewest side effects for you, which is safe in pregnancy or with your kidney function, and which one the community can afford to keep in reserve. A narrow older agent that reaches high urinary levels is often the better clinical answer than a broad intravenous-class drug that also happens to be marked S.

The reserve argument is not abstract. Health agencies list antimicrobial-resistant infections and Clostridioides difficile colitis among the real harms of unnecessary or excessively broad antibiotic use. Every broad-spectrum course you take makes the next infection — yours or someone else's — a little harder to treat. If your prescription does not match the flashiest line on the report, that is usually deliberate, and it is fair to ask why so you understand the reasoning.

06

What happens if you stop the course early?

Health service advice is consistent on this point: take all the medicine you are prescribed, even if you start to feel better. Symptoms settle when the bacterial load drops, which happens well before the population is cleared. Stopping at that moment leaves behind the organisms that survived longest — precisely the ones least troubled by that drug — and they are the population that regrows.

The practical result is a relapse a week or two later that no longer responds to the same tablet, and a repeat culture that now shows resistance where the first showed susceptibility. The opposite error is just as real, though: courses have been getting shorter as evidence accumulates, and an uncomplicated bladder infection is often treated for only a few days. The rule is not 'longer is safer' but 'finish exactly what was prescribed, and go back if you are not better in two days rather than adding a leftover strip from home'.

One exception belongs alongside that rule. Finishing the course does not mean pushing through a reaction to it: a rash, wheeze or swelling of the face, lips or tongue, severe or bloody diarrhoea, or a new tendon or nerve problem are reasons to contact the prescriber straight away rather than to keep taking the tablets. Stopping for a genuine adverse effect, with a replacement arranged, is a different thing from stopping because you feel better.

07

Repeated urinary infections — which tests come next?

Recurrence is defined by pattern rather than by feeling, and the first step is proof: a culture taken before antibiotics for at least one of the episodes, so that everyone knows whether the same organism keeps returning or a new one appears each time. Relapse with an identical organism raises the question of a persistent focus such as a stone, an obstruction, incomplete bladder emptying or, in men, the prostate. Reinfection with different organisms points more towards behaviour and mucosal factors.

Depending on that answer the next tests are typically an ultrasound of the kidneys, ureters and bladder with a post-void residual measurement, blood glucose and kidney function, and in selected cases referral for cystoscopy. National advice for recurrent infection includes options such as a different antibiotic, a low-dose preventive antibiotic taken for up to six months, and vaginal oestrogen after menopause. Repeated blind courses without a single properly taken culture is the one approach that reliably fails.

08

Why the rules are different in pregnancy

Pregnancy is the clearest exception to the principle that bacteria in urine without symptoms should be left alone. Screening for and treating asymptomatic bacteriuria in pregnancy has been shown to be beneficial, reducing the risk of pyelonephritis, low birthweight and preterm delivery. That is why a routine antenatal urine culture exists at all, and why a positive result is treated even when you feel entirely well.

Two practical consequences follow. First, the culture is worth doing properly, since a contaminated sample can lead to an unnecessary course in pregnancy. Second, the antibiotic choice is narrower, because several agents that are ordinary options otherwise are avoided at particular stages, so this is not a situation for leftover tablets or a pharmacy suggestion. Urinary symptoms during pregnancy should prompt an urgent appointment rather than watchful waiting.